Publication | Closed Access

Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model

Breast OncologyMedicineImmunologyImmune Checkpoint InhibitorBreast CancerTumor TargetingInhibits Tumor GrowthCell BiologyTumor BiologyCancer Growth